[1] [2] Have questions about Mounjaro
Pipeline triple agonists targeting GLP-1, GIP, and glucagon reveal early metabolic gains that could reset therapeutic benchmarks after 2027
What to do with a patient on GLP-1 (Glucagon-like peptide-1) receptor agonist therapy who is losing inches but not weight?
Domestic US travel: Prescription peptides: Carry prescription, keep in original packaging Research peptides: No specific laws against, but recommend discrete packaging International travel: Prescription peptides: Bring prescription, declare at customs Research peptides: Risk of seizure at customs, laws vary by destination country Recommendation: Don't travel internationally with research peptides (high seizure risk) TSA: Allows peptides in carry-on with syringes for medical use
Mounjaro clinical data The table below summarises Mounjaro alongside the other GLP-1 medications most often used for weight management in the UK
Images from the operation show boxes of Izempic, prefilled tirzepatide pens, and retatrutide, a drug that is still in clinical trials and not available publicly
